These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 31929980

  • 1. A Randomized Placebo-Controlled N-of-1 Trial: The Effect of Proton Pump Inhibitor in the Management of Gastroesophageal Reflux Disease.
    Sierra-Arango F, Castaño DM, Forero JD, Pérez-Riveros ED, Ardila Duarte G, Botero ML, Cárdenas A, De la Hoz-Valle J.
    Can J Gastroenterol Hepatol; 2019; 2019():3926051. PubMed ID: 31929980
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rapid resolution of sleep disturbances related to frequent reflux: effect of esomeprazole 20 mg in two randomized, double-blind, controlled trials.
    Johnson DA, Le Moigne A, Hugo V, Nagy P.
    Curr Med Res Opin; 2015 Feb; 31(2):243-50. PubMed ID: 25478944
    [Abstract] [Full Text] [Related]

  • 4. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease.
    Bayerdörffer E, Bigard MA, Weiss W, Mearin F, Rodrigo L, Dominguez Muñoz JE, Grundling H, Persson T, Svedberg LE, Keeling N, Eklund S.
    BMC Gastroenterol; 2016 Apr 14; 16():48. PubMed ID: 27080034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G, Wenzl TG, Thomson M, Omari T, Barker P, Lundborg P, Illueca M.
    J Pediatr; 2013 Sep 14; 163(3):692-8.e1-2. PubMed ID: 23800403
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of Postprandial Administration of Esomeprazole on Reflux Symptoms in Gastroesophageal Reflux Disease: A Randomized, Controlled Trial.
    Boltin D, Zvidi I, Raskin M, Kayless H, Schmilovitz-Weiss H, Gingold-Belfer R, Niv Y, Dickman R.
    Dig Dis; 2018 Sep 14; 36(4):257-263. PubMed ID: 29791895
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial.
    Karkon Varnosfaderani S, Hashem-Dabaghian F, Amin G, Bozorgi M, Heydarirad G, Nazem E, Nasiri Toosi M, Mosavat SH.
    J Integr Med; 2018 Mar 14; 16(2):126-131. PubMed ID: 29526236
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.
    Vakil NB, Shaker R, Johnson DA, Kovacs T, Baerg RD, Hwang C, D'Amico D, Hamelin B.
    Aliment Pharmacol Ther; 2001 Jul 14; 15(7):927-35. PubMed ID: 11421866
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of esomeprazole for treatment of poorly controlled asthma.
    American Lung Association Asthma Clinical Research Centers, Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, Wise RA.
    N Engl J Med; 2009 Apr 09; 360(15):1487-99. PubMed ID: 19357404
    [Abstract] [Full Text] [Related]

  • 14. Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial.
    Chiang HH, Wu DC, Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Yao CC, Tsai CE, Liang CM, Wang YK, Wang JW, Huang CF, Chuah SK, Taiwan Acid-Related Disease Study Group.
    Drug Des Devel Ther; 2019 Apr 09; 13():1347-1356. PubMed ID: 31118571
    [Abstract] [Full Text] [Related]

  • 15. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.
    Franke A, Hepp C, Harder H, Beglinger C, Singer MV.
    Scand J Gastroenterol; 2008 Apr 09; 43(12):1425-31. PubMed ID: 18924018
    [Abstract] [Full Text] [Related]

  • 16. The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor.
    Jones R, Patrikios T.
    Int J Clin Pract; 2008 Dec 09; 62(12):1844-50. PubMed ID: 19166433
    [Abstract] [Full Text] [Related]

  • 17. GERD assessment including pH metry predicts a high response rate to PPI standard therapy.
    Kandulski A, Peitz U, Mönkemüller K, Neumann H, Weigt J, Malfertheiner P.
    BMC Gastroenterol; 2013 Jan 16; 13():12. PubMed ID: 23324360
    [Abstract] [Full Text] [Related]

  • 18. Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.
    Sakurai K, Suda H, Fujie S, Takeichi T, Okuda A, Murao T, Hasuda K, Hirano M, Ito K, Tsuruta K, Hattori M.
    Dig Dis Sci; 2019 Mar 16; 64(3):815-822. PubMed ID: 30415407
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.